| 000 | 01524 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517192904.0 | ||
| 264 | 0 | _c20181018 | |
| 008 | 201810s 0 0 eng d | ||
| 022 | _a1607-8454 | ||
| 024 | 7 |
_a10.1080/10245332.2017.1419600 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCurtis, S A | |
| 245 | 0 | 0 |
_aA patient with oxaliplatin immune-induced syndrome (OIIS) who also developed leucovorin and palonosetron-associated thrombocytopenia. _h[electronic resource] |
| 260 |
_bHematology (Amsterdam, Netherlands) _cAug 2018 |
||
| 300 |
_a429-432 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aAutoantibodies _ximmunology |
| 650 | 0 | 4 |
_aBlood Platelets _ximmunology |
| 650 | 0 | 4 | _aErythrocyte Indices |
| 650 | 0 | 4 | _aHemolysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xadverse effects |
| 650 | 0 | 4 | _aOxaliplatin |
| 650 | 0 | 4 | _aPlatelet Count |
| 650 | 0 | 4 |
_aRectal Neoplasms _xcomplications |
| 650 | 0 | 4 |
_aThrombocytopenia _xblood |
| 700 | 1 | _aCurtis, B R | |
| 700 | 1 | _aLee, A I | |
| 700 | 1 | _aHendrickson, J E | |
| 700 | 1 | _aLacy, J | |
| 700 | 1 | _aPodoltsev, N A | |
| 773 | 0 |
_tHematology (Amsterdam, Netherlands) _gvol. 23 _gno. 7 _gp. 429-432 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/10245332.2017.1419600 _zAvailable from publisher's website |
| 999 |
_c27929181 _d27929181 |
||